Olaniyan Olanrewaju, Owolabi Mayowa O, Akinyemi Rufus O, Salako Babatunde L, Hurst Samantha, Arulogun Oyedunni, Gebregziabher Mulugeta, Uvere Ezinne, Ovbiagele Bruce
Department of Economics, University of Ibadan, Nigeria.
Department of Medicine, University of Ibadan, Nigeria (
eNeurologicalSci. 2015 Jun;1(2):38-45. doi: 10.1016/j.ensci.2015.09.003.
The economic and social costs of stroke to the society can be enormous. These costs can cause serious economic damage to both the individual and the nation. It is thus important to conduct a cost effectiveness analysis to indicate whether an intervention provides high value where its health benefits justify its costs. This study will provide evidence based on the costs of stroke with a view of improving intervention and treatments of stoke survivors in Nigeria. This study utilizes two types of economic evaluation methods - cost-effectiveness analysis and cost-benefit analysis - to determine the economic impact of Tailored Hospital-based Risk Reduction to Impede Vascular Events after Stroke (THRIVES) intervention. The study is conducted in four Nigerian hospitals where 400 patients are recruited to participate in the study. The cost-effectiveness of THRIVES post-discharge intervention is compared with the control Intervention scenario, which is the usual and customary care delivered at each health facility in terms of cost per quality adjusted life years (QALYs). It is expected that successful implementation of the project would serve as a model of cost-effective quality stroke care for implementation.
中风给社会带来的经济和社会成本可能是巨大的。这些成本会给个人和国家都造成严重的经济损失。因此，进行成本效益分析以表明一种干预措施在其健康效益证明其成本合理的情况下是否具有高价值就显得很重要。本研究将基于中风成本提供证据，以期改善尼日利亚中风幸存者的干预措施和治疗方法。本研究采用两种经济评估方法——成本效益分析和成本效益分析——来确定基于医院的中风后血管事件定制风险降低干预措施（THRIVES）的经济影响。该研究在尼日利亚的四家医院进行，招募了400名患者参与研究。将THRIVES出院后干预措施的成本效益与对照干预方案进行比较，对照干预方案是各医疗机构提供的常规和惯常护理，以每质量调整生命年（QALY）的成本来衡量。预计该项目的成功实施将成为实施具有成本效益的优质中风护理的典范。
